EP2947098
COMBINATION OF ANTI-CTLA4 ANTIBODY WITH GEMCITABINE FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.10.2009EP published:
20.11.2019EP application number:
15166232.7
EPO information:
European Patent Register
Max expiry date:
28.10.2029
Title:
COMBINATION OF ANTI-CTLA4 ANTIBODY WITH GEMCITABINE FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES
Timeline
Today
29.10.2009EP application
20.11.2019EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
LEE, Francis, Y.Address:
Princeton, NJ New Jersey, US
Name:
JURE-KUNKEL, MariaAddress:
Princeton, NJ New Jersey, US
Priority
Number:
226910 PDate:
20.7.2009Country:
US
Number:
462168Date:
30.7.2009Country:
US
Number:
PCT/US2009/052209Date:
30.7.2009Country:
WO
Classification
Categories:
C07K 16/28, C07K 16/18, A61K 31/385, A61K 31/337, A61K 33/24, A61K 31/506, A61K 39/00, A61P 35/00, A61K 45/06, A61K 39/395